EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exopolysaccharides from Lactiplantibacillus plantarum WLPL04 Alleviate Hyperuricemia by Regulating Uric Acid Metabolism and Gut Microbiota

Min Wei, Yingsheng Hu, Xiaoxian Li, Xingyi Long, Zhihong Zhang, Xueying Tao, Hua Wei

Foods · 02.04.2026 · 15 (7) · 1206

DOI: 10.3390/foods15071206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Foods, online erschienen am 02.04.2026. Verfasst von Min Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperuricemia (HUA) is associated with excessive uric acid (UA) production, impaired renal excretion, and gut microbial dysbiosis. This study aims to systematically evaluate the alleviating effects of exopolysaccharide (EPS04) derived from Lactiplantibacillus plantarum WLPL04 on HUA.

Methods

The study employed both in vitro HK-2 cells and in vivo animal studies in HUA mice. Key methods included assessing xanthine oxidase (XOD) activity and reactive oxygen species (ROS) production in vitro and measuring serum UA levels, renal function parameters, XOD activity, and gene expression in vivo. Additionally, 16S rRNA sequencing was used to analyze gut microbiota composition.

Results

EPS04 reduced UA production in HK-2 cells by inhibiting XOD activity and downregulating its gene expression while also decreasing XOD-derived ROS. EPS04 significantly lowered serum UA levels and attenuated renal injury in HUA mice. Hepatic XOD expression and activity were downregulated, reducing UA production, while UA excretion was enhanced through upregulation of renal ABCG2 expression. Furthermore, EPS04 increased gut microbiota α-diversity, restored the Bacteroidota/Firmicutes ratio, and enriched beneficial taxa, including Akkermansia and Dubosiella.

Conclusions

EPS04 alleviates HUA through inhibition of XOD activity, upregulation of renal ABCG2 expression, and modulation of gut microbiota, suggesting its potential as a nutraceutical biopolymer for dietary management of HUA and related metabolic disorders.

Schlagwörter

Stichwörter der Autor:innen

Lactiplantibacillus plantarumexopolysaccharidegut microbiotahyperuricemiauric acid metabolism

Autor:innen und Institutionen

  • State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangxi

Zitieren

APA

Wei, M., Hu, Y., Li, X., Long, X., Zhang, Z., Tao, X., & Wei, H. (2026). Exopolysaccharides from Lactiplantibacillus plantarum WLPL04 Alleviate Hyperuricemia by Regulating Uric Acid Metabolism and Gut Microbiota. Foods, 15(7), 1206. https://doi.org/10.3390/foods15071206

Vancouver

Wei M, Hu Y, Li X, Long X, Zhang Z, Tao X, et al. Exopolysaccharides from Lactiplantibacillus plantarum WLPL04 Alleviate Hyperuricemia by Regulating Uric Acid Metabolism and Gut Microbiota. Foods. 2026;15(7):1206. doi:10.3390/foods15071206

BibTeX
@article{Wei2026,
  author = {Wei, Min and Hu, Yingsheng and Li, Xiaoxian and Long, Xingyi and Zhang, Zhihong and Tao, Xueying and Wei, Hua},
  title = {Exopolysaccharides from Lactiplantibacillus plantarum WLPL04 Alleviate Hyperuricemia by Regulating Uric Acid Metabolism and Gut Microbiota},
  journal = {Foods},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {1206},
  doi = {10.3390/foods15071206}
}
Kostenlos starten →